CARDIOPROGRESS
Foundation for the advancement of cardiology

Up to 60% of stroke survivors may develop cognitive decline within a year Up to 60% of all stroke survivors develop memory and thinking problems within a year, and one-third go on to develop dementia within five years.

Risk of rehospitalization in younger women after heart attack nearly double that of men Women aged 55 years and younger have nearly double the risk of rehospitalization in the year immediately after a heart attack compared to men of similar age, according to a study supported by the National Institutes of Health.

Cancer and heart disease services put at risk by coronavirus response UK Biobank study suggests heart scans could help identify early damage and guide post-treatment care.

Recognizing efforts to reduce the burden of cardiovascular and kidney disease in type 2 diabetes Type 2 diabetes is one of the leading causes of premature cardiovascular death and significantly contributes to cardiovascular morbidity and kidney disease.

Statin Primary Prevention Trial in HIV Halted for Efficacy An international clinical trial testing statin therapy for primary cardiovascular prevention in people living with HIV has been stopped early due to strong evidence of efficacy and safety in this population.

Heart Disease Risk May Start Before Birth A woman's prepregnancy heart health is critical to both her health as well as the health of the children she gives birth to, according to researchers.

Cancer survivors may be at heightened risk of cardiovascular disease An international clinical trial testing statin therapy for primary cardiovascular prevention in people living with HIV has been stopped early due to strong evidence of efficacy and safety in this population.

High Biomarker Level Plus Diabetes Predict Bad PCI Outcomes Among patients with type 2 diabetes and coronary artery disease (CAD) who underwent percutaneous coronary intervention (PCI), those with a high platelet-to-lymphocyte ratio (PLR) at the time of their procedure had a significantly higher risk for major adverse cardiovascular and cerebrovascular events (MACCE) and stent thrombosis compared with similar patients with a low PLR during a median 2.4-year follow-up. Patients with PCI and a high PLR, but without type 2 diabetes, were not at increased risk for these outcomes compared with similar patients with a low PLR.

Dabigatran Recalled Over Potential Carcinogen Ascend Laboratories LLC is recalling 10 lots of the oral anticoagulant dabigatran etexilate capsules (75 mg and 150 mg) because of unacceptable levels of a potential carcinogen.

Treat to LDL Target or High-Intensity Statin for All With Clinical CAD: LODESTAR How secondary prevention statins are given to push LDL cholesterol levels lower, whether in a high-intensity statin regimen or by dosage titration to meet LDL targets, may make little difference to clinical outcomes, suggests a randomized trial.

FDA Approves First Pulsed Field Ablation System for AF The US Food and Drug Administration (FDA) has approved the PulseSelect Pulsed Field Ablation (PFA) System (Medtronic) for the treatment of both paroxysmal and persistent atrial fibrillation (AF), the manufacturer has announced.

A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic Syndrome A growing appreciation of the pathophysiological interrelatedness of metabolic risk factors such as obesity and diabetes, chronic kidney disease, and cardiovascular disease has led to the conceptualization of cardiovascular-kidney-metabolic syndrome. The confluence of metabolic risk factors and chronic kidney disease within cardiovascular-kidney-metabolic syndrome is strongly linked to risk for adverse cardiovascular and kidney outcomes.

3 challenges to watch in global health in 2023 For the first two years of the Covid-19 pandemic, people working in the infectious diseases and global health spheres were largely focused on the new disease. In 2022, however, gears shifted. Covid didn’t go away, but diseases like flu that had been held in abeyance by the new virus and the measures we used to slow its spread — well, they’re baaack. From late summer onward in the United States, hospitals have been packed with people sick with one respiratory illness or another.

ADA Advises New BP, Lipid Targets for People With Diabetes New more aggressive targets for blood pressure and lipids are among the changes to the annual American Diabetes Association (ADA) Standards of Care in Diabetes — 2023. The document, long considered the gold standard for care of the more than 100 million Americans living with diabetes and prediabetes, was published December 12 as a supplement in Diabetes Care. The guidelines are also accessible to doctors via an app; last year's standards were accessed more than 4 million times.

American Heart Association (AHA) Scientific Sessions 2022 AHA’s Scientific Sessions 2022 in hybrid mode took place on Nov. 5-7, 2022, at McCormick Place Convention Center in Chicago, IL.

ACC Calls for More Career Flexibility in Cardiology A new statement from the American College of Cardiology (ACC) is calling for a greater degree of career flexibility in the specialty to promote cardiologists' personal and professional well-being and preserve excellence in patient care.

American Heart Associated A new statement from the American College of Cardiology (ACC) is calling for a greater degree of career flexibility in the specialty to promote cardiologists' personal and professional well-being and preserve excellence in patient care.

American Heart Associations conference

Prof. Aronow's career path Dear colleagues! The Cardioprogress Foundation presents the excerpts from the memoirs of the International Journal of Heart and Vascular Diseases editorial board member Wilbert S. Aronov, a cardiologist, professor of medicine, member of the FACC, FAHA, FACP, FCCP, FASPC, AGSF, FGSA. Dr. Wilbert Solomon Aronow was born in New York City on October 30, 1931. His parents were Russian Jewish immigrants. His grandparents were rabbis in Russia. Doctor Aronov dedicated his professional career to medicine.

World Heart Day 2022 in Iloilo Iloilo province made history for hosting this year’s World Heart Day. It was chosen by the World Health Organization (WHO) as pilot area for the celebration. As highlight of the event, the whole façade of the Iloilo provincial capitol was illuminated on Thursday night, Sept. 29. The ceremonial event was led by Gov. Arthur Defensor Jr.; Department of Health (DOH) undersecretaries Dr. Kenneth Ronquillo and Atty. Charade Grande; DOH Western Visayas regional director, Dr. Adriano Zubaan; and representatives from WHO, Resolve to Save Lives, and World Heart Federation.